Teva close to buying Saraca Labs' API plant in Hyderabad

摘要

Israel's Teva,the world's largest generic drug manufacturer,is looking to acquire Saraca Labs' API plant in Hyderabad,in a deal estimated at around Rs.400 crores.the plant has recently been approved by the US Food and Drug Administration (FDA).